Management of dyslipidemia in pediatric renal transplant recipients.
Clicks: 281
ID: 75922
2020
Dyslipidemia after kidney transplantation is a common complication that has historically been underappreciated, especially in pediatric recipients. It is also a major modifiable risk factor for cardiovascular disease, a top cause of morbidity and mortality of transplant patients. While most knowledge about post-transplant dyslipidemia has been generated in adults, recommendations and treatment strategies also exist for children and are presented in this review. Awareness of these applicable guidelines and approaches is required, but not sufficient, for the reliable management of dyslipidemia in our patients, and additional needs and opportunities for comprehensive care in this area (e.g., quality improvement) are outlined.
| Reference Key |
bock2020managementpediatric
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bock, Margret E;Wall, Leslie;Dobrec, Carly;Chandran, Mary;Goebel, Jens; |
| Journal | pediatric nephrology (berlin, germany) |
| Year | 2020 |
| DOI | 10.1007/s00467-019-04428-y |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.